• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION INTELLANAV MIFI OPEN-IRRIGATED; CATHETER, PERCUTANEOUS, CARDIAC ABLATION, FOR TREATMENT OF ATRIAL FLUTTER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION INTELLANAV MIFI OPEN-IRRIGATED; CATHETER, PERCUTANEOUS, CARDIAC ABLATION, FOR TREATMENT OF ATRIAL FLUTTER Back to Search Results
Model Number 87047
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code Atrial Fibrillation (1729)
Date of Event 01/09/2024
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
A.4.Weight: 89.81 kg the device has not been received for analysis; therefore, a failure analysis of the complaint device could not be completed.
 
Event or Problem Description
Clinical study (b)(6) for interrupt af; subject id: (b)(6) it was reported that following an ablation procedure with an intellanav mifi open-irrigated, the patient experienced atrial fibrillation with rapid ventricular responses.The patient was evaluated at outside emergency room and an electrocardiogram (ecg) was performed.The patient's heart rate was between 160-180.Diltiazem 20 mg intravenous (iv) bolus was administered and converted to normal sinus rhythm (nsr).The patient's rhythm then converted back to atrial fibrillation and an additional bolus dose of diltiazem 10 mg iv was administered.The patient remained in nsr.The patient was discharged with the following medication changes; to stop metoprolol tartrate and initiate metoprolol succinate 200 mg daily.The event outcome was listed as ongoing.It is unknown of device is available for return.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INTELLANAV MIFI OPEN-IRRIGATED
Common Device Name
CATHETER, PERCUTANEOUS, CARDIAC ABLATION, FOR TREATMENT OF ATRIAL FLUTTER
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
302 parkway, global park
la aurora - heredia
CS  
Manufacturer Contact
timothy degroot
4100 hamline avenue north
dc a330
saint paul, MN 55112
6515826168
MDR Report Key19043343
Report Number2124215-2024-20595
Device Sequence Number8472167
Product Code OAD
UDI-Device Identifier08714729938361
UDI-Public08714729938361
Combination Product (Y/N)N
Initial Reporter StateNH
Initial Reporter CountryUS
PMA/510(K) Number
P150005/S017
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Study,Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial
Report Date (Section B) 04/04/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date06/18/2025
Device Model Number87047
Device Catalogue Number87047
Device Lot Number0031847236
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 03/12/2024
Initial Report FDA Received Date04/04/2024
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured06/19/2023
Is the Device Labeled for Single Use? (Y/N) Yes
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age69 YR
Patient SexMale
-
-